PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer

NAKASUKA, Takamasa

doi:10.1016/j.lungcan.2023.01.018

ID	66055
Title Alternative	PD-1阻害は、Egfr変異陽性肺癌においてAd-SGE-REICにより誘導されるCD8+T細胞依存性抗腫瘍免疫を増強する
FullText URL	K0006888_abstract_review.pdf 293 KB K0006888_fulltext.pdf 373 KB K0006888_other1.pdf 1.11 MB K0006888_other2.pdf 770 KB K0006888_other3.pdf 165 KB K0006888_summary.pdf 159 KB
Author	NAKASUKA, Takamasa Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Note	岡山大学審査学位論文 This is an Accepted Manuscript of the article : Nakasuka T, Ohashi K, Nishii K, Hirabae A, Okawa S, Tomonobu N, Takada K, Ando C, Watanabe H, Makimoto G, Ninomiya K, Fujii M, Kubo T, Ichihara E, Hotta K, Tabata M, Kumon H, Maeda Y, Kiura K. PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer. Lung Cancer. 2023 Apr;178:1-10. doi: 10.1016/j.lungcan.2023.01.018. © 2023 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ This fulltext file will be available in Feb. 2024.
Published Date	2023-09-25
Content Type	Thesis or Dissertation
Grant Number	甲第6888号
Granted Date	2023-09-25
Thesis Type	Doctor of Philosophy in Medical Science
Grantor	岡山大学
Thesis FullText	Thesis or Dissertation (See FullText URL)
Related Url	isVersionOf https://doi.org/10.1016/j.lungcan.2023.01.018
language	English
File Version	ETD
Grant ID	15301甲第6888号
PubMed ID	36753780
Copyright Holders	© 2023 Elsevier B.V.
DOI	10.1016/j.lungcan.2023.01.018
License	https://creativecommons.org/licenses/by-nc-nd/4.0/